1. Home
  2. CRDL vs QSG Comparison

CRDL vs QSG Comparison

Compare CRDL & QSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDL
  • QSG
  • Stock Information
  • Founded
  • CRDL 2017
  • QSG 2019
  • Country
  • CRDL Canada
  • QSG China
  • Employees
  • CRDL N/A
  • QSG N/A
  • Industry
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • QSG Other Consumer Services
  • Sector
  • CRDL Health Care
  • QSG Real Estate
  • Exchange
  • CRDL Nasdaq
  • QSG Nasdaq
  • Market Cap
  • CRDL 104.5M
  • QSG 99.2M
  • IPO Year
  • CRDL N/A
  • QSG 2023
  • Fundamental
  • Price
  • CRDL $1.23
  • QSG $2.17
  • Analyst Decision
  • CRDL Strong Buy
  • QSG
  • Analyst Count
  • CRDL 3
  • QSG 0
  • Target Price
  • CRDL $9.00
  • QSG N/A
  • AVG Volume (30 Days)
  • CRDL 298.3K
  • QSG 154.3K
  • Earning Date
  • CRDL 11-14-2024
  • QSG 03-06-2025
  • Dividend Yield
  • CRDL N/A
  • QSG N/A
  • EPS Growth
  • CRDL N/A
  • QSG 662.58
  • EPS
  • CRDL N/A
  • QSG 1.03
  • Revenue
  • CRDL N/A
  • QSG $532,696,414.00
  • Revenue This Year
  • CRDL N/A
  • QSG N/A
  • Revenue Next Year
  • CRDL N/A
  • QSG N/A
  • P/E Ratio
  • CRDL N/A
  • QSG $2.06
  • Revenue Growth
  • CRDL N/A
  • QSG 13.53
  • 52 Week Low
  • CRDL $0.96
  • QSG $1.47
  • 52 Week High
  • CRDL $3.12
  • QSG $6.22
  • Technical
  • Relative Strength Index (RSI)
  • CRDL 35.88
  • QSG 50.30
  • Support Level
  • CRDL $1.17
  • QSG $1.60
  • Resistance Level
  • CRDL $1.30
  • QSG $1.95
  • Average True Range (ATR)
  • CRDL 0.08
  • QSG 0.19
  • MACD
  • CRDL 0.00
  • QSG 0.04
  • Stochastic Oscillator
  • CRDL 17.65
  • QSG 85.10

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

About QSG QuantaSing Group Limited

QuantaSing Group Ltd is a learning service provider in China's adult learning market for personal interest courses. It offers easy-to-understand, affordable, and accessible online courses to adult learners under various brands, including QiNiu, Kelly, and QianChi among others empowering them to pursue personal development. The company offers courses for various domains such as financial literacy, skill upgrading, recreation, and leisure which are offered in live large-class dual-instructor mode, online community-based training camp mode, and in live lecture, one-on-one tutoring mode. Its segments are; Learning service and others which derives key revenue, and Consumer business. Geographically, the company generates all of its revenue from the People's Republic of China.

Share on Social Networks: